Category Archives: Press Release

Scitech Development Announces Promising Preliminary Results in Phase 1a Trial for T-cell Non-Hodgkin Lymphoma

Scitech Development Announces Promising Preliminary Results in Phase 1a Trial for T-cell Non-Hodgkin Lymphoma NEWS PROVIDED BY SciTech Development 03 Dec, 2024, 10:00 ET **Multiple Early Partial Responses Alongside Encouraging Safety and Pharmacokinetic Data**   DETROIT, Dec. 3, 2024 /PRNewswire/ — SciTech Development, a clinical-stage pharmaceutical company focused on advancements in cancer treatment, is excited…

SciTech Development Welcomes John Chapman to the Strategic Advisory Board as Senior Financial Advisor

SciTech Development Welcomes John Chapman to the Strategic Advisory Board as Senior Financial Advisor NEWS PROVIDED BY SciTech Development 15 Oct, 2024, 09:00 ET DETROIT, Oct. 15, 2024 /PRNewswire/ — SciTech Development, Inc., a clinical-stage biotechnology company focused on innovative cancer therapeutics, is pleased to announce the addition of John Chapman, CPA, to its Strategic Advisory…

SciTech Development, Inc. Announces Receipt of Drug Supply From The National Cancer Institute (NCI)

SciTech Development, Inc. Announces Receipt of Drug Supply From The National Cancer Institute (NCI) NEWS PROVIDED BY SciTech Development 17 Sept, 2024, 09:00 ET DETROIT, Sept. 17, 2024 /PRNewswire/ — SciTech Development, Inc., a clinical-stage biotechnology company focused on innovative cancer therapeutics, is pleased to announce that the National Cancer Institute (NCI), part of the National…

SciTech Development Raises Additional $3.2M to Expand Clinical Trials for Cancer

SciTech Development Raises Additional $3.2M to Expand Clinical Trials for CancerSciTech accelerates its mission to bring ST-001 to cancer patients. NEWS PROVIDED BY SciTech Development, LLC 04 Jun, 2024, 09:00 ET GROSSE POINTE FARMS, Mich., June 4, 2024 /PRNewswire/ — SciTech Development, a clinical-stage, specialty oncology pharmaceutical company, today announced it has closed an additional…

SciTech Development Announces First Patient Dosed in Phase 1 Clinical Trial of ST-001

SciTech Development Announces First Patient Dosed in Phase 1 Clinical Trial of ST-001This study is designed to evaluate ST-001 for the treatment of T-cell non-Hodgkin’s lymphoma (NHL). NEWS PROVIDED BY SciTech Development, LLC 20 Dec, 2023, 08:00 ET GROSSE POINTE, Mich., Dec. 20, 2023 /PRNewswire/ — SciTech Development (“SciTech” or the “Company”), a clinical-stage pharmaceutical…

Learn about the Promise of ST-001 from Medical Experts – Catch the SciTech Roundtable Replay Here

Learn about the Promise of ST-001 from Medical Experts – Catch the SciTech Roundtable Replay Here CONTACT David Schaffer

SciTech Development Announces The Formation of a Distinguished Medical Advisory Board With Top Oncology Specialists

SciTech Development Announces The Formation of a Distinguished Medical Advisory Board With Top Oncology Specialists NEWS PROVIDED BY SciTech Development, LLC 26 Oct, 2023, 10:00 ET GROSSE POINTE FARMS, Mich., Oct. 26, 2023 /PRNewswire/ — SciTech Development, LLC, today announced the formation of a distinguished and independent medical advisory board (MAB) comprised of key opinion…

SciTech Readies for First-In-Human Trial with Clinical Supply of ST-001 nanoFenretinide

SciTech Readies for First-In-Human Trial with Clinical Supply of ST-001 nanoFenretinide NEWS PROVIDED BY SciTech Development, LLC 03 Oct, 2023, 17:19 ET GROSSE POINTE FARMS, Mich., Oct. 3, 2023 /PRNewswire/ –.SciTech announced today that it has successfully manufactured the clinical supply of its lead drug candidate, ST-001 nanoFenretinide, to initiate its upcoming clinical trial in T-cell…

SciTech Development Announces IRB Approval for Human Clinical Trials

SciTech Development Announces IRB Approval for Human Clinical TrialsLead cancer drug candidate, ST-001 nanoFenretinide, has received Institutional Review Board (“IRB”) approval for its upcoming clinical trials for T-Cell Lymphomas. NEWS PROVIDED BY SciTech Development, LLC September 14, 2023 GROSSE POINTE FARMS, Mich., September 14, 2023 (Newswire.com) – SciTech Development (“SciTech” or the “Company”), a clinical-stage…

SciTech Development Raises $2.73 Million in Oversubscribed Financing Round to Advance Clinical Trials for Cancer Treatment

SciTech Development Raises $2.73 Million in Oversubscribed Financing Round to Advance Clinical Trials for Cancer Treatment NEWS PROVIDED BY SciTech Development, LLC 07 Jun, 2023, 14:54 ET — Financing Provides for the Advancement of Clinical Trials – GROSSE POINTE FARMS, Mich., June 7, 2023 /PRNewswire/ — SciTech Development today announced it has closed a $2.73M…